NYQ · Medical - Healthcare Information Services
PHR (PHR) Stock
$11.44
+1.24%
NYQ: PHR
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Should Value Investors Buy Phreesia (PHR) Stock?
Zacks · Jul 21, 2026
Phreesia Launches AI Chatbot to Connect Patients With Healthcare Providers
MT Newswires · Jul 21, 2026
MediFind Launches AI-Powered Chatbot to Help Patients Find and Book the Right Provider
Business Wire · Jul 21, 2026
Phreesia (PHR) Stock Fair Value Edges Lower As Analysts Split On Growth Outlook
Simply Wall St. · Jun 19, 2026
Phreesia's (NYSE:PHR) Strong Earnings Are Of Good Quality
Simply Wall St. · Jun 10, 2026
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About PHR
PHR is led by CEO Chaim Indig, employs 2,082 people, headquartered in US, publicly traded since 2019.
PHR stock trades at $11.44 with a market capitalization of $707.13M. The stock is valued at a price-to-earnings (P/E) ratio of 229.25, price-to-book of 1.68, price-to-sales of 1.12. Over the past 52 weeks the stock has ranged between $7.77 and $32.76, and currently trades 65.1% below its 52-week high.
On profitability, PHR generates a return on equity (ROE) of 0.59%, return on capital employed of 0.89%, an operating margin of 0.62%, a net profit margin of 0.48%.